AAAAAA

   
Results: 1-25 | 26-32 |
Results: 26-32/32
Depressive symptomatology and cocaine-induced pituitary-adrenal axis activation in individuals with cocaine dependence
Authors: Elman, I Breiter, HC Gollub, RL Krause, S Kantor, HL Baumgartner, WA Gastfriend, DR Rosen, BR
Citation: I. Elman et al., Depressive symptomatology and cocaine-induced pituitary-adrenal axis activation in individuals with cocaine dependence, DRUG AL DEP, 56(1), 1999, pp. 39-45
The politics of distinction and disobedience: Honor and the defense of liberty in Montesquieu
Authors: Krause, S
Citation: S. Krause, The politics of distinction and disobedience: Honor and the defense of liberty in Montesquieu, POLITY, 31(3), 1999, pp. 469-499
Pharmacological properties of J-104132 (L-753,037), a potent, orally active, mixed ETA/ETB endothelin receptor antagonist
Authors: Nishikibe, M Ohta, H Okada, M Ishikawa, K Hayama, T Fukuroda, T Noguchi, K Saito, M Kanoh, T Ozaki, S Kamei, T Hara, K William, D Kivlighn, S Krause, S Gabel, R Zingaro, G Nolan, N O'Brien, J Clayton, F Lynch, J Pettibone, D Siegl, P
Citation: M. Nishikibe et al., Pharmacological properties of J-104132 (L-753,037), a potent, orally active, mixed ETA/ETB endothelin receptor antagonist, J PHARM EXP, 289(3), 1999, pp. 1262-1270
Electrochemical sensor for measurement of urea and creatinine in serum based on ac impedance measurement of enzyme-catalyzed polymer transformation
Authors: Ho, WO Krause, S McNeil, CJ Pritchard, JA Armstrong, RD Athey, D Rawson, K
Citation: Wo. Ho et al., Electrochemical sensor for measurement of urea and creatinine in serum based on ac impedance measurement of enzyme-catalyzed polymer transformation, ANALYT CHEM, 71(10), 1999, pp. 1940-1946
BEACOPP: A new regimen for advanced Hodgkin's disease
Authors: Diehl, V Franklin, J Hasenclever, D Tesch, H Pfreundschuh, M Lathan, B Paulus, U Sieber, M Ruffer, JU Sextro, M Engert, A Wolf, J Hermann, R Holmer, L Stappert-Jahn, U Winnerlein-Trump, E Wulf, G Krause, S Glunz, A von Kalle, K Bischoff, H Haedicke, C Duhmke, E Georgii, A Loeffler, M
Citation: V. Diehl et al., BEACOPP: A new regimen for advanced Hodgkin's disease, ANN ONCOL, 9, 1998, pp. 67-71
Evolution and future trends of SIMOX material
Authors: Krause, S Anc, M Roitman, P
Citation: S. Krause et al., Evolution and future trends of SIMOX material, MRS BULL, 23(12), 1998, pp. 25-29
BEACOPP, a new dose-escalated and accelerated regimen, is at least as effective as COPP/ABVD in patients with advanced-stage Hodgkin's lymphoma: Interim report from a trial of the German Hodgkin's Lymphoma Study Group
Authors: Diehl, V Franklin, J Hasenclever, D Tesch, H Pfreundschuh, M Lathan, B Paulus, U Sieber, M Rueffer, JU Sextro, M Engert, A Wolf, J Hermann, R Holmer, L Stappert-Jahn, U Winnerlein-Trump, E Wulf, G Krause, S Glunz, A von Kalle, K Bischoff, H Haedicke, C Duehmke, E Georgii, A Loeffler, M
Citation: V. Diehl et al., BEACOPP, a new dose-escalated and accelerated regimen, is at least as effective as COPP/ABVD in patients with advanced-stage Hodgkin's lymphoma: Interim report from a trial of the German Hodgkin's Lymphoma Study Group, J CL ONCOL, 16(12), 1998, pp. 3810-3821
Risultati: 1-25 | 26-32 |